Effects of acotiamide on esophageal motility and EGJ distensibility for gastroesophageal reflux disease.

Effects of acotiamide on esophageal motility and EGJ distensibility for gastroesophageal reflux disease. - effets of acotiamide for GERD

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000032438

Enrollment

Registered

2018-05-01

Start date

2017-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

GERD

Interventions

Acotiamide 300 mg / day for 3 days

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: GERD patients

Exclusion criteria

Exclusion criteria: Post operation of esophagus

Design outcomes

Primary

Measure	Time frame
Changes in esophageal motor function and distensibility of the esophagogastric junction after administration of acotiamide 300 mg / day for 3 days and after the last dose 2 hours.	—

Countries

Japan

Contacts

Public ContactHironobu Mikami

Shimane University Faculty of Medicine Second Department of Internal Medicine

d_h_m202@yahoo.co.jp0853-20-2190

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026